Shipping Industry was one of the hottest stock market segments today. Some of the market analysts believe that the spike in share prices is a response to the Baltic Dry Index (BDI), which is going into a positive territory since been trampled at the 2012. Anyhow, looks like bottom has been formed in the one […]
by BioTechIll Guest Author BIOLASE, Inc. (BIOL) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and Conformité Européene (CE) Mark approval for its EPIC 10™ diode soft tissue laser. EPIC EPIC™ offers the most precise control of tissue cutting for different procedures and tissue biotypes. With our […]
by BiotechIll Guest Author Cell Therapeutics, Inc. (CTIC) today announced that its paclitaxel poliglumex drug OPAXIO has been granted orphan-drug designation by the U. S Food and Drug Administration for the treatment of malignant brain cancer (glioblastoma multiforme). CTIC stock closed up 11.2% on the 4fold of its 10day average volume. Phase 2 study has […]
Peregrine Pharmaceuticals (PPHM ) announced today that it discovered major discrepancies between some patient sample test results and patient treatment code assignments during the course of preparing for an end-of-phase II meeting with regulatory authorities. Peregrine contracted with independent third-party contractors to execute treatment group assignments and oversee clinical trial material coding and distribution according […]
DARA BioSciences, Inc. (DARA) stock posted today 20.95% in gains on 6,424,094 shares in trading volume and brought to followers for about 55% in profits since our alert issued on September 13th. Our “gut feeling” and quick observation of DARA’s financials “told” us that a second offering for this biotech penny markets most likely is […]
Houston American Energy Corp. (NYSE: HUSA) shares ended a trading session with gains of over 29% and closed at the high of the day. HUSA has posted on the Company’s web site presentation slides reflecting site, seismic and geological data with respect to its holdings in the Serrania area in Colombia. Sophisticated investors were curious […]
Quiksilver Inc.’s (NYSE: ZQK) shares jumped today after the clothing company reported a third-quarter profit that topped estimates: Americas revenue increased 10% to $286.1 million from $260.2 million, and was up 12% in constant currency. Europe revenue decreased 13% to $154.1 million from $176.4 million, and was up modestly in constant currency. Asia Pacific revenue […]
Galectin Therapeutics (GALT) develops carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer based on the company’s unique approach of galectin proteins, key mediators of biologic function. Galectin announced today that it has received a notice of issuance from the U.S. Patent and Trademark Office for Patent Number 8,236,780. The patent covers key […]
Astex Pharmaceuticals, Inc. (ASTX) today announced that Janssen-Cilag International NV, who holds marketing and development rights for DACOGEN™ in all markets except the North America, was notified that the CHMP (Committee for Medical Products for Human Use) of the EMA (European Medicines Agency) granted a positive opinion recommending approval of DACOGEN™ for injection in the […]
pSivida Corp. (PSDV) today announced the National Security Agency of Medicines and Health Products (L’Agence Nationale de Sécurité du Médicament et des Produits de Santé) has granted marketing authorization to ILUVIEN® for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies. Dr. Paul Ashton, President and […]
